Eterna Therapeutics Inc. (NASDAQ:ERNA) Sees Significant Increase in Short Interest
Eterna Therapeutics Inc. (NASDAQ:ERNA – Get Free Report) was the recipient of a significant increase in short interest in September. As of September 15th, there was short interest totalling 36,600 shares, an increase of 10.2% from the August 31st total of 33,200 shares. Approximately 1.3% of the company’s stock are sold short. Based on an […]
More Stories
Intertek Group’s (ITRK) “Sector Perform” Rating Reiterated at Royal Bank Of Canada
Royal Bank Of Canada reiterated their sector perform rating on shares of Intertek Group (LON:ITRK – Free Report) in a...
Amazon.com (NASDAQ:AMZN) Stock Price Expected to Rise, JPMorgan Chase & Co. Analyst Says
Amazon.com (NASDAQ:AMZN) had its price objective boosted by JPMorgan Chase & Co. from $240.00 to $255.00 in a research report...
Vistry Group’s (VTY) Buy Rating Reiterated at Deutsche Bank Aktiengesellschaft
Deutsche Bank Aktiengesellschaft reiterated their buy rating on shares of Vistry Group (LON:VTY – Free Report) in a research report...
Secure Trust Bank’s (STB) “House Stock” Rating Reiterated at Shore Capital
Shore Capital reiterated their house stock rating on shares of Secure Trust Bank (LON:STB – Free Report) in a research...
Autodesk (NASDAQ:ADSK) Given Outperform Rating at Macquarie
Macquarie reiterated their outperform rating on shares of Autodesk (NASDAQ:ADSK – Free Report) in a report issued on Friday,Benzinga reports....
Alnylam Pharmaceuticals (NASDAQ:ALNY) Price Target Raised to $404.00
Alnylam Pharmaceuticals (NASDAQ:ALNY – Free Report) had its target price upped by Citigroup from $364.00 to $404.00 in a research...